These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 12851688)

  • 1. Non-small and small cell lung carcinoma cell lines exhibit cell type-specific sensitivity to edelfosine-induced cell death and different cell line-specific responses to edelfosine treatment.
    Shafer SH; Williams CL
    Int J Oncol; 2003 Aug; 23(2):389-400. PubMed ID: 12851688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small cell lung carcinoma exhibits greater phospholipase C-beta1 expression and edelfosine resistance compared with non-small cell lung carcinoma.
    Strassheim D; Shafer SH; Phelps SH; Williams CL
    Cancer Res; 2000 May; 60(10):2730-6. PubMed ID: 10825148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of reactive oxygen species-mediated ERK and JNK activation sensitizes dihydromyricetin-induced mitochondrial apoptosis in human non-small cell lung cancer.
    Kao SJ; Lee WJ; Chang JH; Chow JM; Chung CL; Hung WY; Chien MH
    Environ Toxicol; 2017 Apr; 32(4):1426-1438. PubMed ID: 27539140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The small GTPase RhoA has greater expression in small cell lung carcinoma than in non-small cell lung carcinoma and contributes to their unique morphologies.
    Varker KA; Phelps SH; King MM; Williams CL
    Int J Oncol; 2003 Mar; 22(3):671-81. PubMed ID: 12579323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase enhances chemotherapeutic effects on H460 human non-small cell lung cancer cells through activation of apoptosis.
    Hu Y; Bally M; Dragowska WH; Mayer L
    Mol Cancer Ther; 2003 Jul; 2(7):641-9. PubMed ID: 12883037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium.
    Chuang SM; Wang IC; Yang JL
    Carcinogenesis; 2000 Jul; 21(7):1423-32. PubMed ID: 10874022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung cancer cells.
    Nguyen TT; Tran E; Nguyen TH; Do PT; Huynh TH; Huynh H
    Carcinogenesis; 2004 May; 25(5):647-59. PubMed ID: 14688022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571.
    Wang WL; Healy ME; Sattler M; Verma S; Lin J; Maulik G; Stiles CD; Griffin JD; Johnson BE; Salgia R
    Oncogene; 2000 Jul; 19(31):3521-8. PubMed ID: 10918610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of roles of three mitogen-activated protein kinases induced by chromium(VI) and cadmium in non-small-cell lung carcinoma cells.
    Chuang SM; Yang JL
    Mol Cell Biochem; 2001 Jun; 222(1-2):85-95. PubMed ID: 11678615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of catalytically inactive phospholipase Cbeta disrupts phospholipase Cbeta and mitogen-activated protein kinase signaling and inhibits small cell lung cancer growth.
    Beekman A; Helfrich B; Bunn PA; Heasley LE
    Cancer Res; 1998 Mar; 58(5):910-3. PubMed ID: 9500449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective stress kinase and Bak activation in response to ionizing radiation but not cisplatin in a non-small cell lung carcinoma cell line.
    Viktorsson K; Ekedahl J; Lindebro MC; Lewensohn R; Zhivotovsky B; Linder S; Shoshan MC
    Exp Cell Res; 2003 Oct; 289(2):256-64. PubMed ID: 14499626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of protein kinase C α/βII and activation of c-Jun NH2-terminal kinase mediate glycyrrhetinic acid induced apoptosis in non-small cell lung cancer NCI-H460 cells.
    Song J; Ko HS; Sohn EJ; Kim B; Kim JH; Kim HJ; Kim C; Kim JE; Kim SH
    Bioorg Med Chem Lett; 2014 Feb; 24(4):1188-91. PubMed ID: 24461294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of MSH2 expression by an Hsp90 inhibitor enhances pemetrexed-induced cytotoxicity in human non-small-cell lung cancer cells.
    Tung CL; Chiu HC; Jian YJ; Jian YT; Chen CY; Syu JJ; Wo TY; Huang YJ; Tseng SC; Lin YW
    Exp Cell Res; 2014 Apr; 322(2):345-54. PubMed ID: 24530475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to epidermal growth factor receptor inhibitors in non-small cell lung cancer cells: limited antiproliferative effects and absence of apoptosis associated with persistent activity of extracellular signal-regulated kinase or Akt kinase pathways.
    Janmaat ML; Kruyt FA; Rodriguez JA; Giaccone G
    Clin Cancer Res; 2003 Jun; 9(6):2316-26. PubMed ID: 12796401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial dysfunction is an essential step for killing of non-small cell lung carcinomas resistant to conventional treatment.
    Joseph B; Marchetti P; Formstecher P; Kroemer G; Lewensohn R; Zhivotovsky B
    Oncogene; 2002 Jan; 21(1):65-77. PubMed ID: 11791177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoplasmic reticulum stress in the proapoptotic action of edelfosine in solid tumor cells.
    Nieto-Miguel T; Fonteriz RI; Vay L; Gajate C; López-Hernández S; Mollinedo F
    Cancer Res; 2007 Nov; 67(21):10368-78. PubMed ID: 17974980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An anti-GD2 monoclonal antibody enhances apoptotic effects of anti-cancer drugs against small cell lung cancer cells via JNK (c-Jun terminal kinase) activation.
    Yoshida S; Kawaguchi H; Sato S; Ueda R; Furukawa K
    Jpn J Cancer Res; 2002 Jul; 93(7):816-24. PubMed ID: 12149148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients.
    Vicent S; Garayoa M; López-Picazo JM; Lozano MD; Toledo G; Thunnissen FB; Manzano RG; Montuenga LM
    Clin Cancer Res; 2004 Jun; 10(11):3639-49. PubMed ID: 15173070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proapoptotic role of Hsp90 by its interaction with c-Jun N-terminal kinase in lipid rafts in edelfosine-mediated antileukemic therapy.
    Nieto-Miguel T; Gajate C; González-Camacho F; Mollinedo F
    Oncogene; 2008 Mar; 27(12):1779-87. PubMed ID: 17891170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway but not the MEK/ERK pathway attenuates laminin-mediated small cell lung cancer cellular survival and resistance to imatinib mesylate or chemotherapy.
    Tsurutani J; West KA; Sayyah J; Gills JJ; Dennis PA
    Cancer Res; 2005 Sep; 65(18):8423-32. PubMed ID: 16166321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.